These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34595188)

  • 1. Expression of LOX Suggests Poor Prognosis in Gastric Cancer.
    Zhu J; Luo C; Zhao J; Zhu X; Lin K; Bu F; Yu Z; Zou F; Zhu Z
    Front Med (Lausanne); 2021; 8():718986. PubMed ID: 34595188
    [No Abstract]   [Full Text] [Related]  

  • 2. Overexpression of DGKI in Gastric Cancer Predicts Poor Prognosis.
    Huang C; Zhao J; Luo C; Zhu Z
    Front Med (Lausanne); 2020; 7():320. PubMed ID: 32733904
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinicopathological and prognostic value of lysyl oxidase expression in gastric cancer: a systematic review, meta-analysis and bioinformatic analysis.
    Jia Z; Gao J; Wang Y; Zhou T; Zhang X; Zu G
    Sci Rep; 2022 Oct; 12(1):16786. PubMed ID: 36202905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
    Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
    Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
    [No Abstract]   [Full Text] [Related]  

  • 5. Upregulation of FGD6 Predicts Poor Prognosis in Gastric Cancer.
    Zeng J; Li M; Shi H; Guo J
    Front Med (Lausanne); 2021; 8():672595. PubMed ID: 34291059
    [No Abstract]   [Full Text] [Related]  

  • 6. Lysyl oxidase and hypoxia-inducible factor 1α: biomarkers of gastric cancer.
    Han YL; Chen L; Qin R; Wang GQ; Lin XH; Dai GH
    World J Gastroenterol; 2019 Apr; 25(15):1828-1839. PubMed ID: 31057297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione Peroxidase 8 as a Prognostic Biomarker of Gastric Cancer: An Analysis of The Cancer Genome Atlas (TCGA) Data.
    Zhang X; Zhan D; Li Y; Wang H; Cheng C; Yao Y; Jia J
    Med Sci Monit; 2020 May; 26():e921775. PubMed ID: 32392186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDCA8 as an independent predictor for a poor prognosis in liver cancer.
    Shuai Y; Fan E; Zhong Q; Chen Q; Feng G; Gou X; Zhang G
    Cancer Cell Int; 2021 Mar; 21(1):159. PubMed ID: 33685433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTRA3 Is a Prognostic Biomarker and Associated With Immune Infiltrates in Gastric Cancer.
    Ji C; Sun LS; Xing F; Niu N; Gao HL; Dai JW; Zhou N; Jiang BC
    Front Oncol; 2020; 10():603480. PubMed ID: 33425760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A signature of seven immune-related genes predicts overall survival in male gastric cancer patients.
    Xu X; Lu Y; Wu Y; Wang M; Wang X; Wang H; Chen B; Li Y
    Cancer Cell Int; 2021 Feb; 21(1):117. PubMed ID: 33602220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucoside xylosyltransferase 2 as a diagnostic and prognostic marker in gastric cancer via comprehensive analysis.
    Zhao Y; Hu S; Zhang J; Cai Z; Wang S; Liu M; Dai J; Gao Y
    Bioengineered; 2021 Dec; 12(1):5641-5654. PubMed ID: 34506251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC01094 Predicts Poor Prognosis in Patients With Gastric Cancer and is Correlated With EMT and Macrophage Infiltration.
    Ye Y; Ge O; Zang C; Yu L; Eucker J; Chen Y
    Technol Cancer Res Treat; 2022; 21():15330338221080977. PubMed ID: 35254147
    [No Abstract]   [Full Text] [Related]  

  • 13. LUM Expression and Its Prognostic Significance in Gastric Cancer.
    Chen X; Li X; Hu X; Jiang F; Shen Y; Xu R; Wu L; Wei P; Shen X
    Front Oncol; 2020; 10():605. PubMed ID: 32500021
    [No Abstract]   [Full Text] [Related]  

  • 14. CTHRC1 Is Associated With Immune Escape and Poor Prognosis in Gastric Cancer.
    Hu Y; Huang L; Zhao K; Li Y; Givens NT; Heslin AJ; Deng Z; Cao L; Fang Y
    Anticancer Res; 2023 Jan; 43(1):115-126. PubMed ID: 36585164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High
    Yuan L; Hu C; Yu P; Bao Z; Xia Y; Zhang B; Wang Y
    Ann Transl Med; 2022 Sep; 10(18):990. PubMed ID: 36267769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. THBS2 is Closely Related to the Poor Prognosis and Immune Cell Infiltration of Gastric Cancer.
    Zhang S; Yang H; Xiang X; Liu L; Huang H; Tang G
    Front Genet; 2022; 13():803460. PubMed ID: 35186032
    [No Abstract]   [Full Text] [Related]  

  • 17. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
    Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
    Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of oncogene cadherin-6 correlates with tumor progression and a poor prognosis in gastric cancer.
    Zhao Z; Li S; Li S; Wang J; Lin H; Fu W
    Cancer Cell Int; 2021 Sep; 21(1):493. PubMed ID: 34530820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of CXCR4 as a Prognostic Biomarker Associated With the Tumor Immune Microenvironment in Gastric Cancer.
    Gu Y; Gu W; Xie R; Chen Z; Xu T; Fei Z
    Front Cell Dev Biol; 2021; 9():654504. PubMed ID: 34568309
    [No Abstract]   [Full Text] [Related]  

  • 20. Infiltrating Immune Cells in Gastric Cancer: A Novel Predicting Model for Prognosis.
    Li W; Li M; Wang H; Peng Y; Dong S; Lu Y; Wang F; Xu F; Liu L; Zhao Q
    J Cancer; 2021; 12(4):965-975. PubMed ID: 33442396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.